Related Experiment Video
Updated: May 10, 2026
04:37
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Bacillus anthracis peptidoglycan activates human platelets through FcγRII and complement
Dawei Sun1, Narcis I Popescu, Brent Raisley
1Department of Cell Biology, University of Oklahoma, Oklahoma City, OK, USA.
Blood
|June 5, 2013
Summary
Peptidoglycan (PGN) from gram-positive bacteria activates human platelets, potentially causing sepsis-related bleeding and clotting issues. This activation involves immune complexes and complement, highlighting a new mechanism in gram-positive sepsis.
Area of Science:
- Immunology
- Hematology
- Microbiology
Background:
- Sepsis often involves platelet activation, leading to vascular leakage and coagulation problems.
- Peptidoglycan (PGN) from gram-positive bacteria is linked to systemic inflammation in sepsis.
Purpose of the Study:
- To investigate the effects of PGN on human platelet activation.
- To elucidate the mechanisms by which PGN activates platelets.
Main Methods:
- Flow cytometry and fluorescent microscopy were used to analyze human platelets.
- Platelet aggregation, integrin activation, and phosphatidylserine (PS) exposure were measured.
- The roles of immunoglobulin G (IgG), Fcγ receptor IIa (FcγRIIa), and complement activation were assessed.
Main Results:
- PGN induced platelet aggregation, αIIbβ3 activation, and PS exposure.
- These effects were dependent on IgG and FcγRIIa signaling.
- PS exposure was mediated by complement activation, leading to C5b-9 deposition and accelerated prothrombinase activity.
Conclusions:
- PGN, when complexed with anti-PGN antibodies, acts as a potent platelet agonist.
- This PGN-mediated platelet activation may contribute to coagulation dysfunction in gram-positive bacterial infections.
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:27Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...